A weak positive association between male pattern baldness and ischemic heart disease has been suggested previously. The authors examined this issue by using data from the Epidemiologic Follow-up Study of the First National Health and Nutrition Examination Survey. As part of the baseline medical examination between 1971 and 1975, the presence and degree of male alopecia (none, minimal, moderate, and severe) were recorded for a subset of participants. Among 3,932 men aged 25-76 years who had complete data, 378 deaths and 939 incident events from ischemic heart disease occurred during an average follow-up period of 14 years. Among 2,019 men who were younger than age 55 years at baseline (61 deaths and 239 incident events of ischemic heart disease), severe baldness was positively associated with ischemic heart disease mortality (rate ratio = 2.51, 95% confidence interval 1.01-6.24) and somewhat less associated with ischemic heart disease incidence (rate ratio = 1.72,95% confidence interval 0.96-3.08). No dose-response relation with degree of baldness was seen. Although these findings are tempered by the absence of information concerning the type of baldness (frontal or vertex), they provide support for earlier studies that indicate male pattern baldness that occurs before age 55 years may be by some mechanism related to ischemic heart disease. Am J Epidemiol 1996;143:651-7. age factors; alopecia; coronary disease; cohort studies; men; risk factors Several case-control and cohort studies have reported a positive association between baldness and coronary heart disease among men. A review, published in 1990, summarized the results from two crosssectional studies (1, 2), four case-control studies (3-6), and two prospective studies (7, 8) and concluded that a weak positive association between male pattern baldness and coronary artery disease was supported by the available data (9). The review listed several short-
comings of the studies such as failure to control adequately for other cardiovascular risk factors including age; misclassification arising from inadequate measures of baldness; the temporal nature of the association of baldness with ischemic heart disease, especially for case-control studies; and inadequate evaluation of baldness subgroups.
Subsequently, a large case-control study of men younger than age 55 years with myocardial infarction found an association between heart disease and male pattern baldness involving the vertex scalp, but not the frontal scalp (10) . Although the odds ratio for any vertex baldness compared with no hair loss was 1.4 (95 percent confidence interval (Cl) 1.2-1.9), the odds ratio increased with increasing degrees of vertex baldness, reaching 2.8 (95 percent Cl 1.6-4.8) for severe baldness. Another recently published study of a sample of Italian men examined the relation between cardiovascular disease risk factors and baldness, finding that men with fronto-occipital baldness had higher cholesterol levels and systolic blood pressure levels than did men with no baldness or only frontal baldness (11) .
Because few data are available on this topic, especially from prospective studies, we examined the relation between baldness and ischemic heart disease in the National Health and Nutrition Examination Survey I (NHANES I) Epidemiologic Follow-up Study.
MATERIALS AND METHODS
Between 1971 and 1975, 18,836 persons aged 12-74 years participated in NHANES I, of whom 14,407 persons aged 25 years or older at the baseline examination were subsequently followed. The methods of the original NHANES I survey and the NHANES I Epidemiologic Follow-up Study have been presented in detail elsewhere (12-16). Cohort members have been followed through 1987.
Only participants from the first 65 sampling locations received the dermatologic examination. This sample with proper weighting is representative of the United States population. Analysis in this study was limited to the 4,479 male participants who had a dermatologic examination. A summary description of the dermatologic examination, which was performed by third-year dermatology residents, has been published previously (17) . Four levels of alopecia were coded: none, minimum, moderate, and severe. Minimum baldness corresponded to no obvious baldness when the participant walked into the examination room, but baldness was detected during the examination. Moderate baldness corresponded to observable baldness upon the first encounter with the participant. Severe baldness corresponded to obvious baldness at first encounter, and if the participant had any hair, it was confined to the fringes (M. T. Johnson, personal communication, High Falls, New York, 1995). The examiners recorded their evaluation of the level of baldness for each participant, but made no distinction between frontal or vertex baldness.
Potential confounders in the analysis were age, race, education, cigarette smoking, systolic pressure, antihypertensive medication, cholesterol, body mass index, and self-reported diabetes. For smoking, we used a variable that was constructed in part from responses obtained during the baseline interview and in part from the first follow-up interview, conducted from 1982 through 1984. The validity of this approach has been demonstrated (18, 19) .
A single blood pressure measurement was obtained in the sitting position for some participants, and two blood pressures were obtained for a subgroup of participants. Only the first blood pressure was used. A single cholesterol measurement was obtained by using a modification of the Abell-Kendall method (16) . Diabetes status was defined from affirmative answers to the question, "Has a doctor ever told you that you have diabetes, and if so, do you still have it?" or to the questions. "Do you have any reason to think that you may have diabetes, sometimes called sugar diabetes or sugar disease?" and "Did a doctor tell you that you had it?" Deaths were classified as being due to ischemic heart disease if the underlying code listed one of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 410-414. Ischemic heart disease incidence was defined as the earlier occurrence of a death based on the underlying code or a hospitalization with the ICD-9-CM codes 410-414 listed among any of the 10 possible diagnoses. Participants who reported at baseline that they had had a previous heart attack were excluded from the analysis.
Deaths were identified through searches of the National Death Index, through the Health Care Financing Administration enrollee files, and by other tracing mechanisms. A participant was considered deceased only if a death certificate was received or a proxy interview was completed to verify the death. Death certificates have been obtained for 96.8 percent of deceased participants. Participants were asked about hospitalizations during the study period. If any were reported, permission was asked to abstract certain data such as admission and discharge dates and diagnoses. Medical records were recorded by trained medical coders using ICD-9-CM codes.
With the direct method, means for continuous variables, proportions of categorical variables, and rates of ischemic heart disease mortality and incidence were age-adjusted using five age groups for all men and three age groups for men younger than 55 years derived to the 1980 US population. We tested for linear trend of various ischemic heart disease risk factors across levels of baldness by conducting linear regression analyses for continuous dependent variables and logistic regression analyses for categorical dependent variables. We also tested for linear trends of mortality and incidence rates across levels of baldness. In these trend analyses, we assigned a value of one to four to the levels of baldness. To examine the independent predictive power of male pattern baldness, we used proportional hazards regressions that included age, age squared, race, education, smoking status, systolic pressure, antihypertensive medication, cholesterol, diabetes, and body mass index. All analyses presented in this paper were performed with the software SUDAAN (20) , which accounts for the complex sam-pling design of the study. Proportionality assumptions were checked using the SAS procedure Proc PHREG by creating time-dependent covariates for the independent variables (21) . The effect on the regression coefficients of stratifying on variables that did not meet the proportionality assumptions was tested using Proc PHREG and was found to be minimal.
RESULTS
Of the 4,479 men who participated in the dermatologic examination, 3,994 men had data on baldness, age, and cause of death after those who were lost to follow-up and prevalent cases of myocardial infarction at baseline were eliminated. A total of 3,932 men who had complete data for all variables were included in the proportional hazards regression analyses. Among these men, there were 378 deaths from ischemic heart disease and 939 incident events of ischemic heart disease. Among men younger than age 55 years, 2,019 men had complete data. Among these men, 61 deaths and 239 incident events of ischemic heart disease were recorded.
Participants who were lost to follow-up were younger, had less education, had a lower mean body mass index, and were more likely to be current smokers than were participants who were included in the analyses. The two groups did not differ significantly in age-adjusted mean cholesterol, systolic pressure, and prevalence of diabetes.
Overall, 47.5 percent of the 3,994 men had some degree of male pattern baldness: 17.5 percent had minimum baldness, 23.1 percent had moderate baldness, and 6.9 percent had severe baldness. Among all men, a significant increasing linear trend across categories of baldness was present only for age (table 1) . The mean body mass index level among participants with severe baldness was higher than that among participants with lesser degrees of baldness. Among men younger than age 55 years, a significant increasing linear trend for the percentage of current smokers was also noted. In addition, men with severe baldness had higher levels of cholesterol than men did with no baldness, had a higher mean body mass index than did men with lesser degrees of baldness, and had the highest prevalence of smoking. Among men aged 55 years and older, significant linear trends were observed for age and body mass index. The difference in cholesterol levels between moderate and severe baldness was significant.
In general, ischemic heart disease mortality and incidence rates were the highest among men with severe baldness (table 2) . However, none of the linear trends were statistically significant.
Male pattern baldness was not associated with an increased rate of mortality from or incidence of ischemic heart disease among all men in this study (table  3) . Neither in a reduced proportional hazards model with age, race, and education nor in the full model did male pattern baldness significantly predict mortality from ischemic heart disease.
Because the literature suggested that baldness was a risk factor for younger men, we examined an agebaldness interaction by dichotomizing age into younger than 55 years and 55 years and older. For the incidence analysis but not for the mortality analysis, the model containing the interaction terms was significantly different from the model without the interaction terms.
Among men younger than age 55 years, the rate ratios for severe male pattern baldness were 2.51 (95 percent CI 1.01-6.24) for ischemic heart disease mortality and 1.72 for incidence (95 percent CI 0.96-3.08) (table 3). A significantly elevated rate ratio for minimal baldness was also found among younger men for ischemic heart disease incidence. However, no consistent dose-response effect according to degree of baldness was present. A determination was made during the examination about whether or not the baldness was familial. The models containing this variable as a main effect as well as an interaction with baldness showed no evidence that this familial baldness was a significant predictor over and above baldness alone.
DISCUSSION
In this study of a nationally representative sample of men in the United States, we found evidence that severe male pattern baldness among men younger than 55 years predicted mortality from and incidence of ischemic heart disease. The association between severe baldness among younger men and ischemic heart disease agrees with the results from previous studies (10) . In addition, some significant differences in ischemic heart disease risk factors according to degree of baldness were present, particularly among the younger men. This is only the third prospective study to examine the association between baldness and ischemic heart disease. Persson and Johansson (7) followed 464 men for 17 years. Of bald men, 25.5 percent developed coronary artery disease compared with 19.7 percent of men who were not bald. However, baldness was not specifically defined in the study, and no adjustments were made for other cardiovascular risk factors. In the Chicago Peoples Gas Company Study, 1,594 men aged 40-59 years were followed from 1958 through 1983 (8) . Only among men who were age 40-49 years did baldness predict the development of coronary artery disease. In that study, men with advanced baldness had higher cholesterol levels than did men with less baldness.
The possible association between male pattern baldness and ischemic heart disease has not been well explained. Male pattern baldness is clearly not a direct risk factor for ischemic heart disease, but rather a marker for some other underlying risk factor (9) . A hormonal hypothesis related to excess androgens is usually proposed as a factor common to both alopecia and ischemic heart disease (9, 10, 22) . Although an excess of androgens is thought to be associated with baldness, available evidence does not strongly support a role for an elevated level of androgens as a risk factor for ischemic heart disease. Several case-control studies have found either lower levels of dihydrotestosterone and testosterone (23) (24) (25) (26) (27) (28) or similar levels (29-31) among myocardial survivors and patients with severe atherosclerosis compared with controls. Baldness may be related to ischemic heart disease through its association with other unmeasured risk factors.
Advantages of our study include its prospective nature and representativeness and the inclusion of various other ischemic heart disease risk factors. However, as in other studies, we were unable to distinguish between frontal and vertex baldness because the location of baldness was not collected at the baseline examination. This distinction may be important because vertex baldness has been associated with cardiovascular disease, whereas frontal baldness has not (2, 10) . However, it is likely that severely bald men would have a significant component of vertex baldness. In addition, baldness can be caused by various conditions. Insofar as baldness from other causes mimics male pattern baldness, some misclassification is also conceivable. Little is known about the reliability or validity of the baseline examinations. However, trained third-year dermatology residents conducted the dermatologic portion of the examination. It seems likely that misclassification of baldness was most pronounced between minimum and moderate baldness. This may account for the lack of a graded dose response according to level of baldness. Endpoints were determined principally from death certificates, hospital records, and interviews with survivors or proxies. Therefore, some degree of misclassification of outcome undoubtedly occurred. If this misclassification were random, then the likely effect would have been an underestimation of the associations.
In summary, we found a positive association between severe male pattern baldness and ischemic heart disease among men younger than age 55 years. This association is consistent with other published reports. Although the underlying mechanism for this association is unclear, the presence of severe male pattern baldness may help to identify individuals with an increased risk of ischemic heart disease. Because no underlying mechanism has been identified, no direct intervention is currently available, and therefore, the question arises about how to counsel a severely bald patient. Cardiovascular risk factors should be reviewed carefully in such patients, who should be encouraged to improve their cardiovascular risk profiles.
